
Nilda Furfaro
Nilda Furfaro is the former president of HLB Pharma Group, who recently made headlines by defending the company against allegations of involvement in a fatal incident involving contaminated fentanyl. She claims that the company has been subject to a media campaign of defamation and emphasizes that there have been no instances of their product being found outside the regulated supply chain. Furfaro's statements come amid a federal investigation into the deaths of at least 52 patients, as she seeks to clarify the company's position and counter claims of negligence.
Global Media Ratings
Countries Mentioned
Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
---|---|---|---|---|---|---|---|---|
Argentina | 1 | 5.00 | 0.08% | +10% | 45,195,774 | 37,493 | $450,000 | 373$ |
Totals | 1 | 45,195,774 | 37,493 | $450,000 | 373$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Argentina:
Nilda Furfaro is under house arrest due to her age.
5
Argentina:
Nilda Furfaro, the mother of Ariel García Furfaro, was granted house arrest due to her age after being indicted.
5
Argentina:
Nilda Furfaro is the mother of the García Furfaro brothers and was placed under house arrest due to her age.
6
Argentina:
Nilda Furfaro is the mother of Ariel Fernando García Furfaro and is implicated in the case.
3
Argentina:
Nilda Furfaro was arrested as she presided over one of the companies involved in the fentanyl case.
3
Paraguay:
Nilda Furfaro is the mother of Ariel García Furfaro and serves as the vice president of HLB.
6
Paraguay:
Nilda Furfaro, the mother of the García Furfaro brothers, was also apprehended during the investigation.
5
Argentina:
Nilda Furfaro, the mother of Ariel García Furfaro, was also detained as part of the investigation.
5
Argentina:
Nilda Furfaro is the mother of the García Furfaro brothers and a former president of HLB Pharma.
5
Argentina:
Nilda Furfaro is identified as the 'president' of HLB Pharma amidst the ongoing scandal.
5